Biohebe: Accelerating Regenerative Medicine

Biohebe provides business development and company formation for therapies that fundamentally reverse degenerative and age-driven diseases. Therapies include genetic vectors, biologics, compounds, stem cells, as well as diagnostics and technologies that support such therapies. Biohebe collaborates with a range of different entities including laboratories, pharmaceutical companies, venture capital and other biotech groups.  All therapies must show exceptional results at either the rodent level or in diseased human cells.

Regenerative therapy is any medical treatment that reverses damage and disease caused by aging or injury.